'Bytes not Books': Active Clinical Decision Support improve healthcare outcomes
Source: BI-ME , Author: Posted by BI-ME staff
Posted: Wed May 16, 2012 1:40 pm

UAE. As a global provider of clinical drug knowledge, First Databank (FDB) is pleased to announce its latest whitepaper, titled "Bytes not Books" (http://bit.ly/IXZRmQ), highlighting the benefits of active Clinical Decision Support (CDS) over passive CDS in medication management.

The whitepaper highlights independent research showing that active CDS improves healthcare outcomes and reduces the occurrence of Adverse Drug Events (ADEs). This is achieved through the use of actionable alerts to highlight drug specific information such as drug-drug interactions, duplicate therapy and drug allergies integrated into a variety of healthcare applications.

Medication management is one such area where CDS has had a positive impact on prescribing behaviour, patient safety and return on investment.

Clinicians in the Middle East are now able to benefit from active CDS from a wide range of healthcare settings such as hospitals, insurance and retail pharmacy by using Middle East Drug Knowledge from FDB. The latest drug knowledgebase includes registered drugs for all countries in the Gulf Cooperation Council and includes many other features.

Darren Nichols is the Managing Director of FDB and says "There is a growing demand for active CDS from healthcare insurers, providers and governments across the Middle East. FDB aims to fill the gap in offering active CDS drug knowledge, services and expert guidance in this area".

First Databank is exhibiting at HIMSS Middle East in Abu Dhabi on 20-21st May on stand 202. For more information visit http://www.firstdatabank.ae

About First Databank (FDB)
FDB provides drug knowledge that helps healthcare professionals make precise medication-related decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver a wide range of valuable, useful, and differentiated solutions. As the company that virtually launched the medication decision support category, we offer more than 30 years of experience in transforming drug knowledge into actionable, targeted, and effective solutions that improve patient safety and healthcare outcomes.

For more information, please vivit www.firstdatabank.ae

 

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: February 12, 2016
INTERNATIONAL. A Syria in which the regime and IS, rather than other rebel groups, are the only real domestic players turns Bashar al-Assad into a pivotal cog in the fight against jihadism. That is something Saudi Arabia cannot allow to happen. To turn the tide, it needs a United States that is engaged and willing to do its bit.
date:Posted: February 11, 2016
INTERNATIONAL. "Although we anticipate some strain on Gulf banks' funding and liquidity this year, good asset quality and strong capitalization remain positive factors."
date:Posted: February 10, 2016
UAE. Low oil prices will constrain the amount of funding available to Gulf sovereigns and banks to support the region's substantial infrastructure bill in coming years; S&P projects a gap as large as $270 billion through 2019 between capital spending for projects and project contracts awarded.
INTERNATIONAL. A Syria in which the regime and IS, rather than other rebel groups, are the only real domestic players turns Bashar al-Assad into a pivotal cog in the fight against jihadism. That is something Saudi Arabia cannot allow to happen. To turn the tide, it needs a United States that is engaged and willing to do its bit.
dhgate
Monogram Ring